-
1
-
-
30444444679
-
Development of effective vaccines against pandemic influenza
-
Subbarao K., Murphy B.R., and Fauci A.S. Development of effective vaccines against pandemic influenza. Immunity 24 1 (2006) 5-9
-
(2006)
Immunity
, vol.24
, Issue.1
, pp. 5-9
-
-
Subbarao, K.1
Murphy, B.R.2
Fauci, A.S.3
-
2
-
-
0025241767
-
Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice
-
Treanor J.J., Tierney E.L., Zebedee S.L., Lamb R.A., and Murphy B.R. Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice. J Virol 64 3 (1990) 1375-1377
-
(1990)
J Virol
, vol.64
, Issue.3
, pp. 1375-1377
-
-
Treanor, J.J.1
Tierney, E.L.2
Zebedee, S.L.3
Lamb, R.A.4
Murphy, B.R.5
-
3
-
-
0032874490
-
A universal influenza A vaccine based on the extracellular domain of the M2 protein
-
Neirynck S., Deroo T., Saelens X., Vanlandschoot P., Jou W.M., and Fiers W. A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat Med 5 10 (1999) 1157-1163
-
(1999)
Nat Med
, vol.5
, Issue.10
, pp. 1157-1163
-
-
Neirynck, S.1
Deroo, T.2
Saelens, X.3
Vanlandschoot, P.4
Jou, W.M.5
Fiers, W.6
-
4
-
-
2442671345
-
Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge
-
Liu W., Zou P., and Chen Y.H. Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge. Immunol Lett 93 2-3 (2004) 131-136
-
(2004)
Immunol Lett
, vol.93
, Issue.2-3
, pp. 131-136
-
-
Liu, W.1
Zou, P.2
Chen, Y.H.3
-
5
-
-
0028821987
-
Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein
-
Slepushkin V.A., Katz J.M., Black R.A., Gamble W.C., Rota P.A., and Cox N.J. Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein. Vaccine 13 15 (1995) 1399-1402
-
(1995)
Vaccine
, vol.13
, Issue.15
, pp. 1399-1402
-
-
Slepushkin, V.A.1
Katz, J.M.2
Black, R.A.3
Gamble, W.C.4
Rota, P.A.5
Cox, N.J.6
-
6
-
-
0036330730
-
Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus
-
Heinen P.P., Rijsewijk F.A., de Boer-Luijtze E.A., and Bianchi A.T. Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus. J Gen Virol 83 Pt 8 (2002) 1851-1859
-
(2002)
J Gen Virol
, vol.83
, Issue.PART 8
, pp. 1851-1859
-
-
Heinen, P.P.1
Rijsewijk, F.A.2
de Boer-Luijtze, E.A.3
Bianchi, A.T.4
-
7
-
-
36749090029
-
Characterization of immunity induced by M2e of influenza virus
-
Wu F., Huang J.H., Yuan X.Y., Huang W.S., and Chen Y.H. Characterization of immunity induced by M2e of influenza virus. Vaccine 25 52 (2007) 8868-8873
-
(2007)
Vaccine
, vol.25
, Issue.52
, pp. 8868-8873
-
-
Wu, F.1
Huang, J.H.2
Yuan, X.Y.3
Huang, W.S.4
Chen, Y.H.5
-
8
-
-
67649529544
-
Heterosubtypic protection conferred by combined vaccination with M2e peptide and split influenza vaccine
-
Wu F., Yuan X.Y., Huang W.S., and Chen Y.H. Heterosubtypic protection conferred by combined vaccination with M2e peptide and split influenza vaccine. Vaccine (2008)
-
(2008)
Vaccine
-
-
Wu, F.1
Yuan, X.Y.2
Huang, W.S.3
Chen, Y.H.4
-
10
-
-
0031964257
-
CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen
-
Davis H.L., Weeratna R., Waldschmidt T.J., Tygrett L., Schorr J., and Krieg A.M. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J Immunol 160 2 (1998) 870-876
-
(1998)
J Immunol
, vol.160
, Issue.2
, pp. 870-876
-
-
Davis, H.L.1
Weeratna, R.2
Waldschmidt, T.J.3
Tygrett, L.4
Schorr, J.5
Krieg, A.M.6
-
11
-
-
33646847166
-
Protection capability of recombinant plasmid DNA vaccine containing VP2 gene of very virulent infectious bursal disease virus in chickens adjuvanted with CpG oligodeoxynucleotide
-
Mahmood M.S., Siddique M., Hussain I., Khan A., and Mansoor M.K. Protection capability of recombinant plasmid DNA vaccine containing VP2 gene of very virulent infectious bursal disease virus in chickens adjuvanted with CpG oligodeoxynucleotide. Vaccine 24 22 (2006) 4838-4846
-
(2006)
Vaccine
, vol.24
, Issue.22
, pp. 4838-4846
-
-
Mahmood, M.S.1
Siddique, M.2
Hussain, I.3
Khan, A.4
Mansoor, M.K.5
-
12
-
-
35148818470
-
DNA vaccination with VP2 gene of very virulent infectious bursal disease virus (vvIBDV) delivered by transgenic E. coli DH5alpha given orally confers protective immune responses in chickens
-
Mahmood M.S., Hussain I., Siddique M., Akhtar M., and Ali S. DNA vaccination with VP2 gene of very virulent infectious bursal disease virus (vvIBDV) delivered by transgenic E. coli DH5alpha given orally confers protective immune responses in chickens. Vaccine 25 44 (2007) 7629-7635
-
(2007)
Vaccine
, vol.25
, Issue.44
, pp. 7629-7635
-
-
Mahmood, M.S.1
Hussain, I.2
Siddique, M.3
Akhtar, M.4
Ali, S.5
-
13
-
-
0035825599
-
Oligonucleotide containing CpG motifs enhances immune response to mucosally or systemically administered tetanus toxoid
-
Eastcott J.W., Holmberg C.J., Dewhirst F.E., Esch T.R., Smith D.J., and Taubman M.A. Oligonucleotide containing CpG motifs enhances immune response to mucosally or systemically administered tetanus toxoid. Vaccine 19 13-14 (2001) 1636-1642
-
(2001)
Vaccine
, vol.19
, Issue.13-14
, pp. 1636-1642
-
-
Eastcott, J.W.1
Holmberg, C.J.2
Dewhirst, F.E.3
Esch, T.R.4
Smith, D.J.5
Taubman, M.A.6
-
14
-
-
0031800888
-
CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus
-
Moldoveanu Z., Love-Homan L., Huang W.Q., and Krieg A.M. CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus. Vaccine 16 11-12 (1998) 1216-1224
-
(1998)
Vaccine
, vol.16
, Issue.11-12
, pp. 1216-1224
-
-
Moldoveanu, Z.1
Love-Homan, L.2
Huang, W.Q.3
Krieg, A.M.4
-
15
-
-
33748871919
-
Formulation with CpG ODN enhances antibody responses to an equine influenza virus vaccine
-
Lopez A.M., Hecker R., Mutwiri G., van Drunen Littel-van den Hurk S., Babiuk L.A., and Townsend H.G. Formulation with CpG ODN enhances antibody responses to an equine influenza virus vaccine. Vet Immunol Immunopathol 114 1-2 (2006) 103-110
-
(2006)
Vet Immunol Immunopathol
, vol.114
, Issue.1-2
, pp. 103-110
-
-
Lopez, A.M.1
Hecker, R.2
Mutwiri, G.3
van Drunen Littel-van den Hurk, S.4
Babiuk, L.A.5
Townsend, H.G.6
-
16
-
-
0032738026
-
Advances in vaccine adjuvants
-
Singh M., and O'Hagan D. Advances in vaccine adjuvants. Nat Biotechnol 17 11 (1999) 1075-1081
-
(1999)
Nat Biotechnol
, vol.17
, Issue.11
, pp. 1075-1081
-
-
Singh, M.1
O'Hagan, D.2
-
17
-
-
0036644485
-
Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine model
-
Proietti E., Bracci L., Puzelli S., Di Pucchio T., Sestili P., De Vincenzi E., et al. Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine model. J Immunol 169 1 (2002) 375-383
-
(2002)
J Immunol
, vol.169
, Issue.1
, pp. 375-383
-
-
Proietti, E.1
Bracci, L.2
Puzelli, S.3
Di Pucchio, T.4
Sestili, P.5
De Vincenzi, E.6
-
18
-
-
0034177875
-
Neonatal administration of IL-12 enhances the protective efficacy of antiviral vaccines
-
Arulanandam B.P., Mittler J.N., Lee W.T., O'Toole M., and Metzger D.W. Neonatal administration of IL-12 enhances the protective efficacy of antiviral vaccines. J Immunol 164 7 (2000) 3698-3704
-
(2000)
J Immunol
, vol.164
, Issue.7
, pp. 3698-3704
-
-
Arulanandam, B.P.1
Mittler, J.N.2
Lee, W.T.3
O'Toole, M.4
Metzger, D.W.5
-
19
-
-
2142810269
-
Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity
-
Jegerlehner A., Schmitz N., Storni T., and Bachmann M.F. Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity. J Immunol 172 9 (2004) 5598-5605
-
(2004)
J Immunol
, vol.172
, Issue.9
, pp. 5598-5605
-
-
Jegerlehner, A.1
Schmitz, N.2
Storni, T.3
Bachmann, M.F.4
|